Talcum Powder Lawsuits MDL Schedule Science Day

There will be a science day in the Johnson & Johnson's baby powder cancer lawsuit MDL during which scientific evidence relevant to the proceedings will be presented before the court.

Sunday, December 18, 2016 - The proceedings pursuant to the talcum powder ovarian cancer MDL will proceed with a court ordered science day on January 23. The day will allow baby powder cancer lawyers to discuss the scientific evidence behind their arguments before the court. These meetings do not take place before a jury, not are they recorded for the official record. The days are simply for the court and all parties involved to familiarize each other with what the feel are the most pressing scientific points of interest that will arise over the course of the MDL.

The decision to hold the science day was made following the first organizational conference held by the court on November 16. It was during this time that it was determined that the scientific background of the talcum powder lawsuits was complicated and expansive enough to necessitate a science day to parse through the material coming from both sides. The science day will be followed nearly a month later on February 22 by a third organizational conference.

The science day will detail the medical history of research conducted into the connection between talcum powder and ovarian cancer. Thousands of Johnson & Johnson's baby powder lawsuits are currently pending around the country, claiming that the healthcare company's popular product has shown links to ovarian cancer when used as a female genital hygiene aid. Plaintiffs claim that Johnson & Johnson knowingly marketed the product for this particular purpose while they were aware of the risk their product posed to consumers.

Johnson & Johnson has denied the claims and contest that the science behind the allegations does not support significant action to be taken against the company. Plaintiffs currently are presenting more than 20 studies detailing a connection between talcum powder and ovarian cancer, an overwhelming evidentiary bank of info talcum powder attorneys will be eager to break down for the court.

The reaction to the evidence presented during Johnson & Johnson's baby powder cancer lawsuits trials has been in favor of the plaintiffs. In 2016 alone, three separate trials awarded the plaintiffs a combined $195 million for damages related to their talcum powder lawsuits. These claims were heavily supported by the scientific studies presented to the jury and made enough of an effect to successfully support their allegations.

On the other hand, a New Jersey state court overseeing multicounty litigation recently dismissed a pair of lawsuits after the judge deemed testimony offered by an expert witness did not meet the criteria necessary for the information to be admissible. This expert witness was a doctor who was brought on by the plaintiffs to explain the findings in the research, but the judge did not see the science the witness was presenting as fit to be presented in court.

The science day to be held for the MDL will likely address how the medical evidence has been evaluated in the past and how it will be used moving forward in the proceedings. The order for the science day calls for the information to be presented before the court in an objective manner.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.